
Health authorities have adopted a low-risk stance on red and near-infrared pain management therapy, confirming that protocols utilizing 632 nm light at 67 mW/cm² safely deliver noticeable relief without adverse effects. As market expansion continues, the focus shifts to targeted research for higher-dose effects and device efficacy, while consumer interest remains high due to endorsements from high-profile athletes and on-trend wellness branding. Despite ongoing uncertainties in machine coherence and safety parameters, consumer enthusiasm drives an increasing integration of these therapies in wellness centers.
“A preliminary study with 26 collegiate football players suggests that the therapy could significantly protect players’ brains from inflammation over the course of a football season. The study was led by the University of Utah in partnership with scientists from Brigham Young University.”
“It has become part of the new luxury wellness culture and it’s been embraced by Hollywood actors, professional athletes, models, biohackers, and high-profile entrepreneurs,” says Marta Panera, Foreo’s global director of marketing and communications.”